October 13, 2021 Comments Off on New patent for Abbvie Inc drug VENCLEXTA Posted in: Patent Added Annual Drug Patent Expirations for VENCLEXTA Venclexta is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Abbvie Inc drug VENCLEXTA appeared first on DrugPatent…
October 13, 2021 Comments Off on New patent for Gilead Sciences drug EPCLUSA Posted in: Patent Added Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are fourteen…
The post New patent for Gilead Sciences drug EPCLUSA appeared first on Drug…